Brief: Castle Biosciences Q1 Basic EPS USD -0.09
02/05/2024 21:05
May 02 (Reuters) - Castle Biosciences Q1 revenue USD 72.974 million vs. IBES estimate USD 66.2 million. * Q1 operating expenses USD 78.445 million * Q1 operating income USD -5.471 million * Q1 net income USD -2.534 million vs. IBES estimate USD -9.05 million * Q1 pretax profit USD -2.489 million vs. IBES estimate USD -9.07 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million